| Line 177: |
Line 177: |
| | *NSAIDs (phenylbutazone, flunixin meglumine) to control pyrexia, inflammation and discomfort | | *NSAIDs (phenylbutazone, flunixin meglumine) to control pyrexia, inflammation and discomfort |
| | *DMSO IV in a 20% solution to control inflamation, provide some analgesia and mild sedation | | *DMSO IV in a 20% solution to control inflamation, provide some analgesia and mild sedation |
| − | *Pentobarbital, diazepam IV, phenobarbital PO or phenytoin IV to control convulsions | + | *Pentobarbital, diazepam IV, phenobarbital PO or phenytoin IV to control seizures |
| | *Antibiotic therapy in cases with secondary bacterial infection | | *Antibiotic therapy in cases with secondary bacterial infection |
| | *Balanced fluid solutions IV or PO as necessary to correct hydration status | | *Balanced fluid solutions IV or PO as necessary to correct hydration status |
| − | *Dietary supplementation (enteral or parenteral if anorexia persists more than 48 hours) | + | *Dietary supplementation (enteral, or parenteral if anorexia persists more than 48 hours) |
| − | *Laxatives to minimize the risk of impaction | + | *Laxatives to reduce the risk of impaction |
| − | *Protection of areas susceptible to self-induced trauma and provision of deep bedding | + | *Protection of body regions susceptible to self-induced trauma and provision of deep bedding |
| − | *Sling support if the horse is recumbent | + | *Sling support for recumbent horses |
| | | | |
| | ====Prognosis==== | | ====Prognosis==== |